CBO Scores $2.5 Billion Deficit Reduction From Multiple Drug Pricing Bills

By John Wilkerson / June 7, 2022 at 3:35 PM

The Congressional Budget Office estimated the budget impact of three Senate drug pricing bills to reform antitrust and patent enforcement laws that combined would reduce the deficit by $1.9 billion over a decade.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.